Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics, 1st Edition
Authors :
John J Cush & Kathryn H. Dao
Date of Publication: 11/2012
Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today––drug safety in a changing world where rheumatoid arthritis (RA) sever ...view more
Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today––drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.
Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today––drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.
Author Information
By John J Cush, Chief, Rheumatology and Clinical Immunology, Presbyterian Hospital of Dallas
Clinical Professor of Internal Medicine, and Kathryn H. Dao
Bring it with you - The Bookshelf app allows you to access books on your laptop, tablet or mobile, so your ebooks go where ever you are - online or offline.
Take notes - Highlight, bookmark and take notes and highlights automatically stay in sync no matter where you make them.
Listen to eBooks - When you need to go screenless, the Text-to-speech tool will read your book aloud.
Powerful search - The searching capabilities allow you to search keywords through all your eBooks, the entire Bookshelf Library and well as on Wikipedia.
Ecological - Manage your environmental impact with paperless books.
How to read your VitalSource eBooks
Purchase your VitalSource eBook on the Elsevier Health site
https://www.eu.elsevierhealth.com/drug-safety-managing-innovation-in-rheumatology-an-issue-of-rheumatic-disease-clinics-9781455750658.html73503Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinicshttps://www.eu.elsevierhealth.com/media/catalog/product/9/7/9781455750658_2.jpg61.4981.99EURInStock/Medicine and Surgery/Rheumatology/Books/Clinics Review Articles9894525503956128371745498285145120Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today––drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities. Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today––drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.00add-to-cart97814557506582012ProfessionalBy John J Cush and Kathryn H. Dao20121Book152w x 229h (6.00" x 9.00")Saunders24019 Nov 2012PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 10 DAYSBy <STRONG>John J Cush</STRONG>, Chief, Rheumatology and Clinical Immunology, Presbyterian Hospital of Dallas
Clinical Professor of Internal Medicine, and <STRONG>Kathryn H. Dao</STRONG>ClinicsThe Clinics: Internal MedicineNoNoNoNoPlease SelectPlease SelectPlease Select
